AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE DUE October 7, 2022G Medical Innovations Holdings Ltd. • July 11th, 2022 • Surgical & medical instruments & apparatus • New York
Company FiledJuly 11th, 2022 Industry JurisdictionTHIS AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE (this “Debenture”) amends and restates that certain 10% Convertible Debenture, originally dated April 7, 2021 (the “Original Debenture”), which was one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due October 7, 2021 (this Debenture, collectively with the other debentures of such original October 2021 series, the “Debentures”).